Stanford researchers have developed Microbe-Independent Deep Assembly and Screening – MIDAS – a polymerase chain ...

Real-time PCR enables faster Mycoplasma detection to meet rigorous cell therapy safety standards and reduce quality control-related workflow delays. Cell therapy innovation is accelerating, but ...

BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at the American Society for Microbiology (ASM) ...

Robust sterility testing is essential to ensure the safety of cell therapies. However, traditional culture-based analysis takes several weeks to confirm a therapeutic’s microbial contamination, which ...

The global food pathogen safety testing equipment and supplies market, valued at USD 9.10 billion in 2026, is projected to reach USD 13.25 billion by 2031, growing at a CAGR of 7.8%. This growth is ...